Journal article
Molecular radiotheragnostics in prostate cancer
Abstract
Two different molecular radio-theragnostic principles are applied in prostate cancer, providing a personalised management for those patients. Firstly, radiopharmaceuticals with the same or similar mechanism of action but different energy (gamma-γ, eg 99mTc-diphosphonates or positron-β+, eg 18F-NaF emitting isotopes) can be used to identify patients with osteoblastic metastases for a treatment with bone seeking beta (β-) or alpha (α-) emitting …
Authors
Du Y; Dizdarevic S
Journal
Clinical Medicine, Vol. 17, No. 5, pp. 458–461
Publisher
Elsevier
Publication Date
October 2017
DOI
10.7861/clinmedicine.17-5-458
ISSN
1470-2118